Your World, Fully Explored.
Get Started
SubscribeLogin
Israel-Hamas Conflict
Pope Leo XIV
Mother's Day
Pope Francis
Baseball
Catholic Church
Military
Social Media
Donald Trump
Cricket
Natural Disasters
Vladimir Putin
Property
Published • loading... • Updated

Baltimore company designing rheumatoid arthritis drug gets OK from FDA to start testing on patients

Summary by Ground News
About 1.5 million Americans suffer from rheumatoid arthritis, a chronic disease. Drugs such as Humira and Enbrel block a molecule called tumor necrosis factor alpha. MyMD-1 can be taken as a tablet, rather than injection or infusion, and its molecules are small.

1 Articles

All
Left
Center
1
Right
The Baltimore SunThe Baltimore Sun
Center

Baltimore company designing rheumatoid arthritis drug gets OK from FDA to start testing on patients

Researchers at MyMD, a Baltimore-based pharmaceutical company, think they’ve developed a new drug to treat rheumatoid arthritis that is safer than others on the market.

·Baltimore, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

The Baltimore Sun broke the news in Baltimore, United States on Monday, October 2, 2023.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Pharma

Pharma

Annapolis

Annapolis

News
For You
SearchBlindspotLocal